WCG and Deep 6 AI Announce Partnership
Collaboration will enable clinical trials as a care alternative for more people and empower greater diversity among research participants.
WCG and Deep 6 AI announced that they are working together to drive more targeted patient recruitment in clinical trials and accelerate enrollment in vital medical research. The relationship brings together WCG's market position, and their investigative sites, biopharma sponsors, CROs, and Deep 6 AI's software. As a result, WCG and Deep 6 AI's collaboration will enable clinical trials as a care alternative for more people and empower greater diversity among research participants.
Read more about this new partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMGSeptember 15th 2025
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
